What is 5-Amino-1MQ?
5-Amino-1MQ is a small synthetic molecule that researchers are studying for its effects on metabolism and body fat. Its full chemical name is a mouthful, so scientists simply call it 5-Amino-1MQ. It belongs to a class of compounds known as NNMT inhibitors — more on what that means in a moment. Unlike many peptides you may have read about, 5-Amino-1MQ is technically a small molecule, meaning it is built from a compact chemical structure rather than a chain of amino acids. That distinction matters because small molecules are often more stable, easier to store, and can sometimes be taken orally. Research on 5-Amino-1MQ is still in relatively early stages, and it is strictly a research compound — not an approved drug or supplement for human use.
How 5-Amino-1MQ Works
To understand 5-Amino-1MQ, you first need to meet the enzyme it targets: NNMT, which stands for nicotinamide N-methyltransferase. Think of NNMT as a dimmer switch inside fat cells. When NNMT activity is high, it quietly drains a key energy currency in the body called SAM (S-adenosyl methionine) and also reduces levels of NAD+, a molecule that cells need to burn fuel efficiently. The result? Fat cells become more sluggish at using energy, and the body tends to store more fat.
5-Amino-1MQ steps in and blocks NNMT — essentially turning that dimmer switch back up. By inhibiting NNMT, the compound is thought to help restore healthier NAD+ and SAM levels inside cells. In theory, this nudges fat cells back toward burning energy rather than hoarding it. Researchers are particularly interested in what happens in adipose tissue (body fat) and muscle when NNMT is inhibited over time. It is a neat mechanism because it targets the metabolic environment of fat cells directly, rather than simply suppressing appetite or blocking fat absorption.
What the Research Shows
Because no numbered sources are available on this page, the following reflects the general landscape of published preclinical and early research on NNMT inhibition and 5-Amino-1MQ specifically.
- Animal studies on obesity: Preclinical work in rodent models has explored whether NNMT inhibition can reduce fat mass. Some studies have reported reductions in body weight and fat tissue in diet-induced obese mice treated with NNMT inhibitors, without major changes in food intake — suggesting a metabolic rather than appetite-based effect.
- NAD+ and cellular energy: Research suggests that blocking NNMT can raise intracellular NAD+ levels. Higher NAD+ is associated with better mitochondrial function — mitochondria are the tiny power plants inside cells — which could translate to improved energy metabolism.
- Muscle and metabolic health: Some early work points to potential benefits in skeletal muscle, where NNMT activity has been linked to muscle wasting conditions. Inhibiting NNMT may help preserve or improve muscle metabolism, though this area needs far more study.
- No human clinical trials yet: It is important to be clear — as of current knowledge, there are no large-scale, peer-reviewed human clinical trials specifically on 5-Amino-1MQ. The evidence base remains predominantly preclinical (cell and animal studies).
What 5-Amino-1MQ Is Being Studied For
Based on its mechanism, researchers are investigating 5-Amino-1MQ across several metabolic areas:
- Obesity and fat loss — Can NNMT inhibition reduce adipose tissue in overweight models?
- Type 2 diabetes and insulin resistance — Does improving cellular NAD+ and SAM levels help cells respond better to insulin?
- Metabolic syndrome — A cluster of conditions including high blood sugar, excess belly fat, and abnormal cholesterol that raises the risk of heart disease.
- Muscle wasting (sarcopenia) — Preserving lean muscle mass in aging or disease models.
- Longevity research — Because NAD+ levels naturally decline with age, compounds that raise NAD+ are of broad interest in aging science.
Again, all of this is research-stage investigation. None of these applications are approved medical treatments.
How 5-Amino-1MQ Is Dosed in Research
Dosing protocols for 5-Amino-1MQ vary across preclinical studies, and no standardized human dosing has been established. Researchers typically work from body-weight-based calculations derived from animal data. For a quick reference, see the dosage chart on this page, and use the interactive calculator to explore weight-adjusted amounts used in published research models. Always remember that research dosing is determined by study design, not by personal health goals, and this compound is not approved for human therapeutic use.
Mixing and Storing 5-Amino-1MQ
5-Amino-1MQ is often supplied as a powder or in capsule form for research purposes. When working with the raw powder in a lab setting, researchers typically dissolve it in a suitable solvent — commonly DMSO (dimethyl sulfoxide) for stock solutions, or a water-based buffer if the protocol requires it. Always check solubility data for your specific batch before mixing. Once dissolved, solutions should be stored in clearly labeled, sealed vials away from light and moisture. Most researchers keep working solutions refrigerated (around 4°C / 39°F) and use them within a few weeks, while longer-term stock solutions are often stored frozen at -20°C (-4°F). Avoid repeated freeze-thaw cycles, as these can degrade the compound over time. Handle all research chemicals with appropriate lab safety protocols, including gloves and eye protection.
EN
BR
ES
FR